Leqselvi Tablet, Film Coated
Product Images NDC 47335-108

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Leqselvi (NDC 47335-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Leqselvi 01)

Chemical structure of deuruxolitinib phosphate showing molecular features including several deuterium atoms (labeled as D), nitrogen-containing rings, a nitrile group (CN), and a phosphoric acid moiety (H3PO4).*

FDA Label Image

Figure 1 (Leqselvi 02)

Two line graphs labeled THRIVE-AA1 and THRIVE-AA2 showing the proportion of subjects with SALT ≤20 response over 24 weeks. Both graphs compare LEQSELVI 8 mg BID (solid line) versus placebo (dashed line), with LEQSELVI showing an increasing response proportion over time compared to placebo.*

FDA Label Image

60 Tablets (Carton Label)

Label for LEQSELVI 8 mg film-coated tablets containing deuruxolitinib phosphate. The label states "Rx Only" and includes directions to dispense with medication guide. It shows a package count of 60 tablets and is labeled by Sun Pharmaceutical Industries, Inc. Dosage and storage instructions are included along with manufacturer and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.